• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

New Normal for Lung Cancer Clinical Trials Under Coronavirus Disease 2019.

作者信息

Zhang Chao, Wu Yi-Long, Zhong Wen-Zhao

机构信息

Division of Pulmonary Oncology, Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, People's Republic of China; Guangdong Provincial Key Laboratory of Translational Medicine in Lung Cancer, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, People's Republic of China; School of Medicine, South China University of Technology, Guangzhou, People's Republic of China.

Division of Pulmonary Oncology, Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, People's Republic of China; Guangdong Provincial Key Laboratory of Translational Medicine in Lung Cancer, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, People's Republic of China.

出版信息

J Thorac Oncol. 2022 May;17(5):588-591. doi: 10.1016/j.jtho.2022.03.001.

DOI:10.1016/j.jtho.2022.03.001
PMID:35465962
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9022460/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8cf7/9022460/bd5b40b1f33b/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8cf7/9022460/bd5b40b1f33b/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8cf7/9022460/bd5b40b1f33b/gr1_lrg.jpg

相似文献

1
New Normal for Lung Cancer Clinical Trials Under Coronavirus Disease 2019.2019冠状病毒病下肺癌临床试验的新常态。
J Thorac Oncol. 2022 May;17(5):588-591. doi: 10.1016/j.jtho.2022.03.001.
2
Short-term safety of an anti-severe acute respiratory syndrome coronavirus 2 messenger RNA vaccine for patients with advanced lung cancer treated with anticancer drugs: A multicenter, prospective, observational study.抗严重急性呼吸综合征冠状病毒 2 信使 RNA 疫苗在接受抗癌药物治疗的晚期肺癌患者中的短期安全性：一项多中心、前瞻性、观察性研究。
Thorac Cancer. 2022 Feb;13(3):453-459. doi: 10.1111/1759-7714.14281. Epub 2021 Dec 28.
3
Lung Cancer Surgical Management During the Outbreak of Coronavirus Disease 2019.2019年冠状病毒病疫情期间的肺癌外科治疗
J Thorac Oncol. 2020 Jun;15(6):e81. doi: 10.1016/j.jtho.2020.03.027. Epub 2020 Apr 11.
4
COVID-19 and lung cancer: risks, mechanisms and treatment interactions.新型冠状病毒肺炎与肺癌：风险、机制和治疗相互作用。
J Immunother Cancer. 2020 May;8(1). doi: 10.1136/jitc-2020-000892.
5
Delayed access to lung cancer screening and treatment during the COVID-19 pandemic: Are we headed for a lung cancer pandemic?2019冠状病毒病大流行期间肺癌筛查与治疗的延迟获取：我们是否正走向肺癌大流行？
Respirology. 2021 Feb;26(2):145-146. doi: 10.1111/resp.13996. Epub 2020 Dec 15.
6
MUC1-C influences cell survival in lung adenocarcinoma Calu-3 cells after SARS-CoV-2 infection.MUC1-C 影响 SARS-CoV-2 感染后肺腺癌 Calu-3 细胞的存活。
BMB Rep. 2021 Aug;54(8):425-430. doi: 10.5483/BMBRep.2021.54.8.018.
7
The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.新冠病毒-19（Sars-Cov-2）的英国变体不应造成疫苗问题。
J Biol Regul Homeost Agents. 2021 Jan-Feb;35(1):1-4. doi: 10.23812/21-3-E.
8
SARS-CoV-2 Infection in Patients with Lung Cancer: Current Clinical Context.肺癌患者的新型冠状病毒2型感染：当前临床背景
Arch Bronconeumol (Engl Ed). 2020 Oct;56(10):684. doi: 10.1016/j.arbres.2020.03.018. Epub 2020 Mar 31.
9
COVID-19: a conundrum to decipher.COVID-19：一个待破译的谜。
Eur Rev Med Pharmacol Sci. 2020 May;24(10):5830-5841. doi: 10.26355/eurrev_202005_21378.
10
analysis identifies neuropilin-1 as a potential therapeutic target for SARS-Cov-2 infected lung cancer patients.分析表明，神经纤毛蛋白-1 可作为 SARS-CoV-2 感染的肺癌患者的潜在治疗靶点。
Aging (Albany NY). 2021 Jun 24;13(12):15770-15784. doi: 10.18632/aging.203159.

引用本文的文献

1
Impact of the COVID-19 pandemic on lung cancer treatment and research.新冠疫情对肺癌治疗与研究的影响。
Genes Dis. 2023 Jul;10(4):1217-1219. doi: 10.1016/j.gendis.2023.01.028. Epub 2023 Mar 24.

本文引用的文献

1
International Association for the Study of Lung Cancer Study of the Impact of Coronavirus Disease 2019 on International Lung Cancer Clinical Trials.国际肺癌研究协会研究 2019 年冠状病毒病对国际肺癌临床试验的影响。
J Thorac Oncol. 2022 May;17(5):651-660. doi: 10.1016/j.jtho.2022.01.017. Epub 2022 Feb 17.
2
Covid-19: Omicron may be more transmissible than other variants and partly resistant to existing vaccines, scientists fear.新冠疫情：科学家担心，奥密克戎毒株可能比其他变种更具传播性，且对现有疫苗有部分抗性。
BMJ. 2021 Nov 29;375:n2943. doi: 10.1136/bmj.n2943.
3
Care disruptions among patients with lung cancer: A COVID-19 and cancer outcomes study.
肺癌患者的护理中断：COVID-19 和癌症结局研究。
Lung Cancer. 2021 Oct;160:78-83. doi: 10.1016/j.lungcan.2021.07.002. Epub 2021 Jul 16.
4
Lung cancer patients with COVID-19 in Spain: GRAVID study.西班牙伴有 COVID-19 的肺癌患者：GRAVID 研究。
Lung Cancer. 2021 Jul;157:109-115. doi: 10.1016/j.lungcan.2021.05.014. Epub 2021 May 14.
5
Efficacy of NVX-CoV2373 Covid-19 Vaccine against the B.1.351 Variant.NVX-CoV2373 新冠疫苗对 B.1.351 变异株的有效性。
N Engl J Med. 2021 May 20;384(20):1899-1909. doi: 10.1056/NEJMoa2103055. Epub 2021 May 5.
6
The potential health and economic value of SARS-CoV-2 vaccination alongside physical distancing in the UK: a transmission model-based future scenario analysis and economic evaluation.英国新冠病毒疫苗接种与保持社交距离相结合的潜在健康和经济价值：基于传播模型的未来情景分析与经济评估
Lancet Infect Dis. 2021 Jul;21(7):962-974. doi: 10.1016/S1473-3099(21)00079-7. Epub 2021 Mar 18.
7
Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant.科维希尔德腺病毒载体新冠疫苗（ChAdOx1 nCoV-19）对 B.1.351 变异株的有效性。
N Engl J Med. 2021 May 20;384(20):1885-1898. doi: 10.1056/NEJMoa2102214. Epub 2021 Mar 16.
8
Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7.SARS-CoV-2 变体 B.1.351 和 B.1.1.7 的抗体抗性。
Nature. 2021 May;593(7857):130-135. doi: 10.1038/s41586-021-03398-2. Epub 2021 Mar 8.
9
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.《全球癌症统计数据 2020：全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
10
Clinical characteristics and risk factors for in-hospital mortality of lung cancer patients with COVID-19: A multicenter, retrospective, cohort study.COVID-19 肺癌患者住院死亡率的临床特征和危险因素：一项多中心、回顾性、队列研究。
Thorac Cancer. 2021 Jan;12(1):57-65. doi: 10.1111/1759-7714.13710. Epub 2020 Nov 3.